Longitudinal assessment of a transgenic animal model of tauopathy by FDG-PET imaging

Journal of Alzheimer's Disease

Volumn 40, Issue S1, 2014, Pages

  De Cristóbal, Javier ^a,b   García García, Luis ^a,c   Delgado, Mercedes ^a   Pérez, Mar ^d   Pozo, Miguel A ^a,e   Medina, Miguel ^b,f  

^a INSTITUTO PLURIDISCIPLINAR   (Spain)

^b Drug Discovery   (Spain)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^d AUTONOMOUS UNIVERSITY OF MADRID   (Spain)

^e Instituto Tecnologico PET   (Spain)

^f CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

Author keywords

Brain metabolism; longitudinal; neuroimaging; tau protein; transgenic mouse

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE; TAU PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN CORTEX; BRAIN METABOLISM; CONTROLLED STUDY; CORPUS STRIATUM; DRUG UPTAKE; FOLLOW UP; GLUCOSE BRAIN LEVEL; GLUCOSE TRANSPORT; HIPPOCAMPUS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NEUROFIBRILLARY TANGLE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TAUOPATHY; TRANSGENIC MOUSE; WILD TYPE; AGING; ANIMAL; BRAIN; DISEASE MODEL; GENETICS; LONGITUDINAL STUDY; METABOLISM; PATHOLOGY; PHOSPHORYLATION; SCINTISCANNING;

AGING; ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; LONGITUDINAL STUDIES; MICE, TRANSGENIC; NEUROFIBRILLARY TANGLES; PHOSPHORYLATION; TAU PROTEINS; TAUOPATHIES;

EID: 84901797935     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-132276     Document Type: Article

References (37)

1. Lee VM, Goedert M, Trojanowski JQ (2001) Neurodegenerative disorders. Annu Rev Neurosci 24, 1121-1159.
2. Hernandez F, Ávila J (2007) Tauopathies. Cell Mol Life Sci 64, 2219-2233. (Pubitemid 47347961)
3. Ludolph AC, Kassubek J, Landwehrmeyer BG, Mandelkow E, Mandelkow EM, Burn DJ, Caparros-Lefebvre D, Frey KA, de Yebenes JG, Gasser T, Heutink P, Höglinger G, Jamrozik Z, Jellinger KA, Kazantsev A, Kretzschmar H, Lang AE, Litvan I, Lucas JJ, McGeer PL, Melquist S, Oertel W, Otto M, Paviour D, Reum T, Saint-Raymond A, Steele JC, Tolnay M, Tumani H, van Swieten JC, Vanier MT, Vonsattel JP,Wagner S, Wszolek ZK, ReisensburgWorking Group for Tauopathies With, Parkinsonism (2009) Tauopaties with parkinsonism clinical spectrum, neuropathological basis, biological markers, and treatment options. Eur J Neurol 16, 297- 309.
4. Hong M, Zhukareva V, Vogelsberg-Ragaglia V, Wszolek Z, Reed L, Miller BI, Geschwind DH, Bird TD, McKeel D, Goate A, Morris JC,Wilhelmsem KC, Schellenberg GD, Trojanowski JQ, Lee VM (1998) Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. Science 282, 1914-1917. (Pubitemid 28555275)
5. Goedert M, Spillantini MG (2001) Tau gene mutations and neurodegeneration. Biochem Soc Symp 67, 59-71. (Pubitemid 33602674)
6. Goedert M (2005) Tau gene mutations and their effects. Mov Disord 20(Suppl. 12), S45-S52. (Pubitemid 41419554)
7. Lim F, Hernández F, Lucas JJ, Gómez-Ramos P, Morán MA, Avila J (2001) FTDP-17 mutations in tau transgenic mice provoke lysosomal abnormalities and Tau filaments in forebrain. Mol Cell Neurosci 18, 702-714. (Pubitemid 34060150)
8. Cataldo AM, Hamilton DJ, Barnett JL, Paskevich PA, Nixon RA (1996) Properties of the endosomal-lysosomal system in the human central nervous system: Disturbances mark most neurons in populations at risk to degenerate in Alzheimer's disease. J Neurosci 16, 186-199. (Pubitemid 26010711)
9. Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, Bergström M, Savitcheva I, Huang GF, Estrada S, Ausén B, Debnath ML, Barletta J, Price JC, Sandell J, Lopresti BJ, Wall A, Koivisto P, Antoni G, Mathis CA, Langström B (2004) Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol 55, 306-319. (Pubitemid 38269583)
10. Zimmer L, Luxen A (2012) PET radiotracers for molecular imaging in the brain: Past, present and future. Neuroimage 61, 363-370.
11. Reiman EM, Uecker A, Gonzalez-Lima F, Minear D, Chen K, Callaway NL, Berndt JD, Games D (2000) Tracking Alzheimer's disease in transgenic mice using fluorodeoxyglucose autoradiology. NeuroReport 11, 987-991. (Pubitemid 30235442)
12. Waerzeggers Y, Monfared P, Viel T, Winkeler A, Jacobs AH (2010) Mouse models in neurological disorders: Applications of non-invasive imaging. Biochim Biophys Acta 1802, 819-839.
13. de Cristóbal J, García-García L, Delgado M, Pozo MA,Medina M (2014) A longitudinal FDG-PET study of transgenic mice overexpressing GSK-3 in the brain. Curr Alzheimer Res, in press.
14. Lüthi A,Van der Putten H, Botteri FM,Mansuy IM, Meins M, Frey U, Sansig G, Portet C, Schmutz M, Schröder M, Nitsch C, Laurent JP, Monard D (1997) Endogenous serine protease inhibitor modulates epileptic activity and hippocampal longterm potentiation. J Neurosci 17, 4688-4699. (Pubitemid 27246926)
15. Navarro P, Guerrero R, Gallego E, Avila J, Luquin R, Garcia-Ruiz PJ, Sanchez MP (2008) Motor alterations are reduced in mice lacking the Park2 gene in the presence of a human FTDP-17 mutant form of four-repeat tau. J Neurol Sci 275, 139-144.
16. Balcerzyk M, Kontaxakis G, Delgado M, García-García L, Correcher C, González AJ, Rubio JL, Benlloch JM, Pozo MA(2009) Initial performance evaluation of a high resolution Albira small animal positron emission tomography scanner with monolithic crystals and depth-of-interaction encoding from a user's perspective. Meas Sci Technol 20, 104011.
17. Ma Y, Smith D, Hof PR, Foerster B, Hamilton S, Blackband SJ, Yu M, Benveniste H (2008) In vivo 3D digital atlas database of the adult C57BL/6J mouse brain by magnetic resonance microscopy. Front Neuroanat 2, 1.
18. Jupp B, O'Brien TJ (2007) Application of coregistration for imaging of animal models of epilepsy. Epilepsia 48(Suppl 4), 82-89. (Pubitemid 47340752)
19. Prieto E, Collantes M, Delgado M, Juri C, García-García L, Molinet F, Fernández-Valle ME, Pozo MA, Gago B, Martí-Climent JM, Obeso JA, Peñuelas I (2011) Statistical parametric maps of 18F-FDG PET and 3-D autoradiography in the rat brain: A cross-validation study. Eur J Nucl Med Mol Imaging 38, 2228-2237.
20. Schmued LC, Stowers CC, Scallet AC, Xu L (2005) Fluoro-Jade C results in ultra high resolution and contrast labeling of degenerating neurons. Brain Res 1035, 24-31. (Pubitemid 40248533)
21. Yamaji S, Ishii K, Sasaki M, Mori T, Kitagaki H, Sakamoto S, Mori E (2000) Evaluation of standardized uptake value to assess cerebral glucose metabolism. Clin Nucl Med 25, 11-16. (Pubitemid 30029912)
22. Wang X, Sarkar A, Cicchetti F, Yu M, Zhu A, Jokivarsi K, Saint-Pierre M, Brownell AL (2005) Cerebral PET imaging and histological evidence of transglutaminase inhibitor cystamine induced neuroprotection in transgenic R6/2 mouse model of Huntington's disease. J Neurol Sci 231, 57-66. (Pubitemid 40439235)
23. Kudo Y, Okamura N, Furumoto S, Tashiro M, Furukawa K, Maruyama M, Itoh M, Iwata R, Yanai K, Arai H (2007) 2-(2-[2-Dimethylaminothiazol-5-yl]ethenyl)-6- (2- [fluoro]ethoxy)benzoxazole: A novel PET agent for in vivo detection of dense amyloid plaques in Alzheimer's disease patients. J Nucl Med 48, 553-561. (Pubitemid 47571409)
24. Duff K, Suleman F (2004) Transgenic mouse models of Alzheimer's disease: Howuseful have they been for therapeutic development? Brief Funct Genomic Proteomic 3, 46-59.
25. Suzuki T, Fujikura K, Higashiyama T, Takata K (1997) DNAstaining for fluorescence and laser confocal microscopy. J Histochem Cytochem 45, 49-53. (Pubitemid 27045364)
26. Ardais AP, Viola GG, Costa MS, Nunes F, Behr GA, Klamt F, Moreira JC, Souza DO, Rocha JB, Porcíuncula LO (2010) Acute treatment with diphenyl diselenide inhibits glutamate uptake into rat hippocampal slices and modifies glutamate transporters, SNAP-25, and GFAP. Toxicol Sci 113, 434-443.
27. Nicholson RM, Kusne Y, Nowak LA, LaFerla FM, Reiman EM, Valla J (2010) Regional cerebral glucose uptake in the 3xTG model of Alzheimer's disease highlights common regional vulnerability across AD mouse models. Brain Res 1347, 179-185.
28. Valla J, Yaari R, Wolf AB, Kusne Y, Beach TG, Roher AE, Corneveaux JJ, Huentelman MJ, Caselli RJ, Reiman EM (2010) Reduced posterior cingulate mitochondrial activity in expired young adult carriers of the APOE 4 allele, the major late-onset Alzheimer's susceptibility gene. J Alzheimers Dis 22, 307-313.
29. Frost B, Jacks RL, Diamond MI (2009) Propagation of tau misfolding from the outside to the inside of a cell. J Biol Chem 284, 12845-12852.
30. Guo JL, Lee VM(2011) Seeding of normal tau by pathological tau conformers drives pathogenesis of Alzheimer-like tangles. J Biol Chem 286, 15317-15331.
31. Kfoury N, Holmes BB, Jiang H, Holtzman DM, Diamond MI (2012) Trans-cellular propagation of Tau aggregation by fibrillar species. J Biol Chem 287, 19440-19451.
32. Clavaguera F, Bolmont T, Crowther RA, Abramowski D, Frank S, Probst A, Fraser G, Stalder AK, Beibel M, Staufenbiel M, Jucker M, Goedert M, TolnayM(2009) Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol 11, 909-913.
33. de Calignon AM, Polydoro M, Suárez-Calvet M, William C, Adamowicz DH, Kopeikina KJ, Pitstick R, Sahara N, Ashe KH, Carlson GA, Spires-Jones TL, Hyman BT (2012) Propagation of tau pathology in a model of early Alzheimer's disease. Neuron 73, 685-697.
34. Liu L, Drouet V, Wu JW, Witter MP, Small SA, Clelland C, Duff K (2012) Trans-synaptic spread of tau pathology in vivo. PLoS One 7, e31302.
35. Iba M, Guo JL, McBride JD, Zhang B, Trojanowski JQ, Lee VM (2013) Synthetic tau fibrils mediate transmission of neurofibrillary tangles in a transgenic mouse model of Alzheimer's-like tauopathy. J Neurosci 33, 1024-1037.
36. Guerrero R, Navarro P, Gallego E, Avila J, de Yébenes JG, Sanchez MP (2008) Park2-null/tau transgenic mice reveal a functional relationship between parkin and tau. J Alzheimers Dis 13, 161-172. (Pubitemid 352038522)
37. Ribé EM, Pérez M, Puig B, Gich I, Lim F, Cuadrado M, Sesma T, Catena S, Sánchez B, Nieto M, Gómez-Ramos P, Morán MA, Cabodevilla F, Samaranch L, Ortiz L, Pérez A, Ferrer I, Avila J, Gómez-Isla T (2005) Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice. Neurobiol Dis 20, 814-822. (Pubitemid 41619357)